SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-20-009265
Filing Date
2020-05-18
Accepted
2020-05-18 07:16:45
Documents
72
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 741519
2 ex31-1.htm EX-31.1 18653
3 ex31-2.htm EX-31.2 11593
4 ex32-1.htm EX-32.1 10973
5 ex32-2.htm EX-32.2 11626
  Complete submission text file 0001493152-20-009265.txt   5247989

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE burg-20200331.xml EX-101.INS 831660
7 XBRL SCHEMA FILE burg-20200331.xsd EX-101.SCH 96870
8 XBRL CALCULATION FILE burg-20200331_cal.xml EX-101.CAL 65569
9 XBRL DEFINITION FILE burg-20200331_def.xml EX-101.DEF 264195
10 XBRL LABEL FILE burg-20200331_lab.xml EX-101.LAB 547115
11 XBRL PRESENTATION FILE burg-20200331_pre.xml EX-101.PRE 356929
Mailing Address 100 OVERLOOK CENTER SUITE 102 PRINCETON NJ 08540
Business Address 100 OVERLOOK CENTER SUITE 102 PRINCETON NJ 08540 609-375-2227
Sonnet BioTherapeutics Holdings, Inc. (Filer) CIK: 0001106838 (see all company filings)

IRS No.: 522102141 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35570 | Film No.: 20888064
SIC: 2834 Pharmaceutical Preparations